Incidence and Clinical Significance of New-Onset Device-Detected Atrial Tachyarrhythmia
- 1 March 2018
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation: Arrhythmia and Electrophysiology
- Vol. 11 (3), e005393
- https://doi.org/10.1161/circep.117.005393
Abstract
Background: Despite the clear association between atrial fibrillation and risk for thromboembolic events (TEs), the clinical significance of new-onset device-detected atrial tachyarrhythmia (DDAT) and TE remains disputed. We aimed to determine the risk of TE in patients with new-onset DDAT. Methods and Results: The OVID Medline, Cochrane, and Scopus databases (inception to November 2016) were searched. Randomized controlled trials, prospective, or retrospective studies of pacemaker or defibrillator patients reporting incidence of DDAT were selected. Summary statistics were used for analysis. Of 4893 reports identified, 28 studies following 24 984 patients were included: average age 69.9 years, 34.7% women, mean study duration 21.8±18.6 months. New-onset DDAT was observed in 23% of patients. Among 9 studies (n=8181) reporting TE, the absolute incidence was 2.1%. TE risk was significantly greater among patients with new-onset DDAT (relative risk [RR], 2.88; 95% CI, 1.79–4.64; PPP=0.01). Notably, the risk of TE was also increased in patients with adjudicated atrial electrograms (RR, 3.60; 95% CI, 2.06–6.30; PP=0.03), even when lower mean thresholds for detection were used. Conclusions: New-onset DDAT is common, affecting close to one quarter of all patients with implanted pacemakers or defibrillators. Adjudication of atrial electrograms further identifies at-risk patients, even when relatively short detection thresholds are used.Keywords
This publication has 46 references indexed in Scilit:
- Pacemaker-Detected Atrial Fibrillation in Patients With Pacemakers: Prevalence, Predictors, and Current Use of Oral AnticoagulationCanadian Journal of Cardiology, 2013
- Subclinical Atrial Fibrillation and the Risk of StrokeThe New England Journal of Medicine, 2012
- Detection of atrial high-rate events by continuous Home Monitoring: clinical significance in the heart failure-cardiac resynchronization therapy populationEP Europace, 2011
- Incidence of paroxysmal atrial tachycardias in patients treated with cardiac resynchronization therapy and continuously monitored by device diagnosticsEP Europace, 2009
- Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapyEP Europace, 2009
- Frequency, Duration, and Predictors of Newly-Diagnosed Atrial Fibrillation Following Dual-Chamber Pacemaker Implantation in Patients Without a Previous History of Atrial FibrillationThe American Journal of Cardiology, 2008
- Asymptomatic Atrial Fibrillation in Pacemaker Recipients: Incidence, Progression, and Determinants Based on the Atrial High Rate TrialPacing and Clinical Electrophysiology, 2007
- Newly Detected Atrial Fibrillation Following Dual Chamber Pacemaker ImplantationJournal of Cardiovascular Electrophysiology, 2006
- Incidence of Atrial Tachyarrhythmias in Pacemaker Patients: Results from the Balanced Evaluation of Atrial Tachyarrhythmias in Stimulated Patients (BEATS) StudyPacing and Clinical Electrophysiology, 2006
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991